Tempus ai inc TEM.US 總覽分析
)TEM 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
TEM 近期報酬表現
10.05%
Tempus ai inc
3.56%
同產業平均
1.47%
S&P500
與 TEM 同產業的標的表現
- ATOS Atossa therapeutics inc價值 3 分趨勢 3 分波段 2 分籌碼 1 分股利 1 分查看更多
TEM 公司資訊
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.